Atlas Trials

Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

Clinical trial NCT06636591 · COMPLETED

Trial details

NCT number
NCT06636591
Sponsor
Fudan University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer FemaleHER2-negative Breast Cancer
Start date
2024-12-23
Primary completion
2026-01-07
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.